trending Market Intelligence /marketintelligence/en/news-insights/trending/1zBOY9A6jgjNvMlBVlllpw2 content esgSubNav
In This List

Liquidia Technologies starts common stock offering

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge


Liquidia Technologies starts common stock offering

Liquidia Technologies Inc. started an underwritten public offering of 3 million common shares.

The late-stage clinical biopharmaceutical company also plans to grant the underwriters an option to buy up to an additional 450,000 shares at the public offering price.

Jefferies and Cowen are acting as joint book-running managers, with Needham & Co. and Wedbush PacGrow as co-managers for the offering.

Morrisville, N.C.-based Liquidia develops and sells human therapeutics using its proprietary Print technology, a particle engineering platform.

Liquidia's lead product candidate LIQ861 — an inhaled dry powder formulation of treprostinil — is in a phase 3 study to treat pulmonary arterial hypertension.